Dr. Stamatouli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
417 N 11th St
Richmond, VA 23298Phone+1 804-828-2161Fax+1 804-828-3673
Education & Training
Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2018
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2012 - 2015
University of Patras School of MedicineClass of 2007
Certifications & Licensure
VA State Medical License 2018 - 2026
CT State Medical License 2015 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Energy Metabolism in Thyroidectomized Patients Start of enrollment: 2020 Oct 28
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 361 citationsCollateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint InhibitorsAngeliki M. Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, Pamela Clark, Harriet M. Kluger
Diabetes. 2018-08-01 - 75 citationsIncreased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes.Jordan J. Wright, Joe-Elie Salem, Douglas B. Johnson, Bénédicte Lebrun-Vignes, Angeliki M. Stamatouli
Diabetes Care. 2018-12-01 - 2 citationsType 2 diabetes mellitus and cardiovascular disease: focus on the effect of antihyperglycemic treatments on cardiovascular outcomes.Ravi Choxi, Sumon Roy, Angeliki M. Stamatouli, Stephanie B. Mayer, Ion S. Jovin
Expert Review of Cardiovascular Therapy. 2020-04-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
